Mount Sinai researchers are pushing the borders of the highly promising science of early detection biomarkers through small RNA expression signatures of circulating extracellular vesicles. A new study aims to measure the impact of liquid biopsy compared to the current standard of care—abdominal ultrasound and serum alpha-fetoprotein—for detection of early-stage hepatocellular carcinoma.